About the journal
Brain Disorders is an open-access journal published by Elsevier in Netherlands, publishing in english. It is listed in DOAJ according to the sources read. Declared publication charge: 2,210 USD. Declared review time at DOAJ: 24 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Elsevier
- ISSN
- 2666-4593
- Country
- Netherlands
- Languages
- english
- Access
- Open access
- Declared publication charge
- 2,210 USD
- Articles in DOAJ
- 299
- Declared review time
- 24 weeks
- Declared peer-review model
- peer_review
- Official website
- https://www.sciencedirect.com/journal/brain-disorders
Index listings
- DOAJ · 2021-08-18
- Indexing
- DOAJ
- APC
- 2,210 USD
- Declared review time (DOAJ)
- 24 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
299
Most recent article
7 months ago
Average review time (journal-declared via DOAJ)
24weeks
Works in OpenAlex
307
Last recorded publication year
2026
h-index
16
i10-index
34
From OpenAlex open data (CC0).
Editorial & policy12
- Last DOAJ review date
- 2026-04-27
- Added to DOAJ
- 2021-08-18
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- CLOCKSSPortico
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Editorial board
- Official page ↗
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 99%
- ORCID iDs in current deposits
- 77%
- Deposits licence metadata at Crossref
- ✓
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity2
- Source type
- journal
- NLM unique ID (PubMed)
- 101775252
Classification2
Subjects (DOAJ)
LCC codes
Subject areas
- Neurological disorders and treatments
- Neurological disorders and treatments
- Alzheimer's disease research and treatments
- Alzheimer's disease research and treatments
- Parkinson's Disease Mechanisms and Treatments
- Parkinson's Disease Mechanisms and Treatments
- Epilepsy research and treatment
- Epilepsy research and treatment
Show all subjects (50)
- Tryptophan and brain disorders
- Tryptophan and brain disorders
- Peripheral Neuropathies and Disorders
- Genetic Neurodegenerative Diseases
- Peripheral Neuropathies and Disorders
- Genetic Neurodegenerative Diseases
- Neuroscience and Neuropharmacology Research
- Neuroscience and Neuropharmacology Research
- Infectious Encephalopathies and Encephalitis
- Infectious Encephalopathies and Encephalitis
- Traumatic Brain Injury and Neurovascular Disturbances
- Traumatic Brain Injury and Neurovascular Disturbances
- Neuroinflammation and Neurodegeneration Mechanisms
- Neuroinflammation and Neurodegeneration Mechanisms
- Mitochondrial Function and Pathology
- Transcranial Magnetic Stimulation Studies
- Mitochondrial Function and Pathology
- Multiple Sclerosis Research Studies
- Transcranial Magnetic Stimulation Studies
- RNA regulation and disease
- Long-Term Effects of COVID-19
- Stroke Rehabilitation and Recovery
- Acute Ischemic Stroke Management
- Long-Term Effects of COVID-19
- Autism Spectrum Disorder Research
- Nuclear Receptors and Signaling
- Stroke Rehabilitation and Recovery
- Acute Ischemic Stroke Management
- Nuclear Receptors and Signaling
- RNA regulation and disease
- Autism Spectrum Disorder Research
- Multiple Sclerosis Research Studies
- Genetics and Neurodevelopmental Disorders
- Genetics and Neurodevelopmental Disorders
- Glioma Diagnosis and Treatment
- Pharmacological Effects and Toxicity Studies
- Cholinesterase and Neurodegenerative Diseases
- Pharmacological Effects and Toxicity Studies
- Cholinesterase and Neurodegenerative Diseases
- Glioma Diagnosis and Treatment
- Dementia and Cognitive Impairment Research
- Dementia and Cognitive Impairment Research
Keywords (DOAJ)
- neurobiology
- neuroscience
- clinical neuroscience
- brain disorders
- neurological diseases
- brain therapeutics
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ